Drugs / MNC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01836562 | Sep 2014 → Jun 2016 | autism | Chaitanya Hospital, Pune | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MNC | “bone marrow derived autologous mono nuclear cells (MNC) (100 million per dose)” NCT01836562 ↗ |
| Modality | Cell therapy | “bone marrow derived autologous mono nuclear cells (MNC)” NCT01836562 ↗ |
| Route | Intrathecal | “Intra thecal injection of autologous MNC” NCT01836562 ↗ |